Evolution of the Average Target: IMPACT Therapeutics, Inc

Evolution of the Target Price: IMPACT Therapeutics, Inc

Changes in Analyst Recommendations: IMPACT Therapeutics, Inc

b557a680fa4e01191ba11d.9WdWjoHCb_TieMBLi4b2Fw0QJiq7dHttwxrKtTOX2rM.uigHvPj6NceUSLoz7NGpOlgjX0HxPANUl2q833eknuyzFSzDx6wVrJAaiQ~431f857631292c7102d503e594344219

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - - +152.07%
+20.3%
+8.11%
+20.6%
+13.84%
+31.04%
-2.54%
+20.78%
+4.21%
-1.19%
Average +26.72%
Weighted average by Cap. +15.60%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
11.29CNY
Average target price
28.52CNY
Spread / Average Target
+152.54%
High Price Target
28.52CNY
Spread / Highest target
+152.54%
Low Price Target
28.52CNY
Spread / Lowest Target
+152.54%

Analyst Consensus Detail

Consensus revision (last 18 months)

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
11.29CNY
Average target price
28.52CNY
Spread / Average Target
+152.54%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7630 Stock
  4. Consensus IMPACT Therapeutics, Inc